The DRUGMATRIX assay focuses on Thromboxane Synthetase enzyme inhibition (substrate: PGH2), which is a Direct single protein target assigned. The assay utilizes Platelet assay cell type and has been conducted on Homo sapiens as the assay organism. Additionally, the test type for this assay is In vitro, and the assay type description is Binding. Does this molecule work well in this assay?